Novel Neisseria Gonorrhoeae Therapeutic Based on CMP-nonulosonate Sugars
- Detailed Technology Description
- Invention encompasses a new strategy to combat drug-resistant gonorrhea. This technology manipulates the lipo-oligosacchride capping of gonococci, thereby decreasing it's fitness and virulence. By in
- Countries
- Not Available
- Application No.
- None
- *Abstract
-
Invention encompasses a new strategy to combat drug-resistant gonorrhea. This technology manipulates the lipo-oligosacchride capping of gonococci, thereby decreasing it's fitness and virulence. By interrupting the sialic acid mediated pathogenesis that contributes to drug-resistance, this intervention can render gonorrhoeae sensitive to killing by the innate immunity system.
- *IP Issue Date
- None
- *IP Type
- Other Patent
- Country/Region
- USA

For more information, please click Here